Skip to content

Topiramate

Published: July 26, 2026Updated: July 26, 2026

Topiramate is an anticonvulsant medication primarily used to treat epilepsy and prevent migraine headaches. It works through multiple mechanisms in the brain to reduce seizure activity and decrease the frequency of migraine attacks. This medication requires proper monitoring and dose titration under medical supervision.

Quick summary

Topiramate is an antiepileptic drug used for seizure control and migraine prevention, working through multiple brain mechanisms.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
N03AX11
RxNorm
38404
Generic
Topiramate
Class
atc-n03
Brands
Qsymia, Trokendi, Qudexy, Topamax, Eprontia
Availability
rx
Lactation
unknown
Routes
oral
Forms
capsule, tablet, solution
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
100mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
25mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
50mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity - serious adverse effects reported with doses exceeding 5000mg
Chronic overdose: Prolonged use at supratherapeutic doses leading to cumulative CNS effects, metabolic acidosis, and cognitive impairment
Immediate actions
Airway management, activated charcoal within 1-2 hours of ingestion, intravenous fluids, monitoring of vital signs and cardiac function
Antidote
No specific antidote exists(Supportive care is the mainstay of treatment; no antidote has proven effectiveness)
Poison Control: 1-800-222-1222

Special Populations

7 groups
✗

pregnancy

first trimester
unsafe
FDA Category
D
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks; discontinue before conception if possible; consider alternative antiepileptic with lower teratogenic risk

Monitor

regular fetal monitoring; detailed anatomy ultrasound at 18-20 weeks

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
D
Dose Adjustment

avoid if possible

Key Recommendations

avoid use near delivery; monitor neonate for withdrawal symptoms and metabolic disturbances

Monitor

fetal growth monitoring; neonatal assessment for withdrawal

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

no specific adjustment

Key Recommendations

use with caution; monitor infant for adverse effects including sedation, irritability, and poor feeding

Monitor

monitor infant for developmental changes, sedation, and weight gain

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children 2 12 years
caution
FDA Category
N
Dose Adjustment

weight-based dosing required; start low and titrate slowly

Key Recommendations

use approved for epilepsy in children 2 years and older; monitor for cognitive effects and behavioral changes

Monitor

regular cognitive and behavioral assessment; monitor growth parameters

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly 65 years and older
caution
FDA Category
N
Dose Adjustment

start at lower dose; titrate slowly

Key Recommendations

use with caution due to increased sensitivity to CNS effects; monitor renal function

Monitor

monitor renal function; assess cognitive status regularly; check for falls

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe creatinine clearance below 30
caution
FDA Category
N
Dose Adjustment

reduce dose by 50%; supplement dose after dialysis

Key Recommendations

dose reduction required; hemodialysis removes approximately 50% of drug

Monitor

monitor renal function regularly; monitor plasma concentrations if available

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate creatinine clearance 30 70
caution
FDA Category
N
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use with caution; consider dose reduction based on clinical response and tolerability

Monitor

monitor renal function; watch for increased side effects

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1996

Initial FDA approval for Topamax (topiramate)

drug_classWHO
2023

Drug class

Value:Anticonvulsant

ATC Classification N03AX11

usageFDA
2023

Common uses

Value:Epilepsy, migraine prevention, weight management

Approved therapeutic indications

brand_namesFDA
2023

Brand names

Value:Topamax, Qsymia, Trokendi, Qudexy, Eprontia

US marketed brand names

Topiramate is FDA-approved for treating partial-onset seizures and generalized tonic-clonic seizures in adults and children, and for preventive treatment of migraine headaches in adults and adolescents 12 years and older.

The exact mechanism is not fully understood, but topiramate is believed to work through multiple pathways including blocking sodium channels, enhancing GABA activity, inhibiting glutamate receptors, and weakly blocking carbonic anhydrase—collectively reducing neuronal excitability and seizure activity.

Common side effects include dizziness, drowsiness, weight loss, and cognitive slowing. Adequate hydration is essential to reduce risk of kidney stones. Do not stop taking this medication abruptly. May cause birth defects if taken during pregnancy. Regular eye exams are recommended due to rare risk of vision changes.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy